WESTERN STANDARD LLC – Merrimack Pharmaceuticals, Inc. Transaction History
WESTERN STANDARD LLC portfolio value:
$4.39M
portfolio value
WESTERN STANDARD LLC quarter portfolio value change:
-36.97%
quarter
Merrimack Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -7.65% | -97.09K shares | -3.15M | $3.75 | 1.17M |
Q2 2022 | share | Increase | +8.28% | 97.09K shares | 754K | $5.95 | 1.26M |
Q1 2022 | share | 0.00% | 0 shares | 2.21M | $6.33 | 1.17M | |
Q4 2021 | share | Decrease | -7.65% | -97.09K shares | -1.54M | $3.93 | 1.17M |
Q3 2021 | share | 0.00% | 0 shares | -1.98M | $4.83 | 1.26M | |
Q2 2021 | share | Increase | +25.50% | 257.98K shares | 1.75M | $6.39 | 1.26M |
Q1 2021 | share | 0.00% | 0 shares | -617K | $6.28 | 1.01M | |
Q4 2020 | share | Decrease | -4.86% | -51.69K shares | 2.71M | $6.89 | 1.01M |
Q3 2020 | share | Increase | +22.31% | 193.91K shares | 1.35M | $4 | 1.06M |
Q2 2020 | share | Increase | +3.14% | 26.44K shares | 1.08M | $3.33 | 869.35K |
Q1 2020 | share | 0.00% | 0 shares | -843K | $2.15 | 842.91K | |
Q4 2019 | share | 0.00% | 0 shares | -1.13M | $3.15 | 842.91K | |
Q3 2019 | share | Increase | +6.15% | 48.84K shares | 13K | $3.98 | 842.91K |
Q2 2019 | share | Increase | +46.88% | 253.43K shares | 824K | $3.32 | 794.06K |
Q1 2019 | share | Increase | +182.89% | 349.52K shares | 2.37M | $3.82 | 540.63K |
Q4 2018 | share | Increase | 0.00% | 191.11K shares | 580K | $2.12 | 191.11K |